FIELD: pharmacology.
SUBSTANCE: digitoxin application is described.
EFFECT: digitoxin effectively reduces TGF-β-induced differentiation of myofibroblasts and can be used to treat idiopathic pulmonary fibrosis with a reduction in the number of complications.
2 dwg
| Title |
Year |
Author |
Number |
| ANTIFIBROLYTIC MEANS |
2016 |
|
RU2621163C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION |
2013 |
- Dygaj Aleksandr Mikhajlovich
- Skurikhin Evgenij Germanovich
- Pershina Ol'Ga Viktorovna
- Reztsova Alena Mikhajlovna
- Ermakova Natalija Nikolaevna
- Krupin Vjacheslav Andreevich
- Khmelevskaja Ekaterina Sergeevna
|
RU2530651C1 |
| METHOD FOR MANUFACTURING PHARMACEUTICAL COMPOSITION IN FORM OF EXTENDED-RELEASE TABLETS CONTAINING PIRFENIDONE AND USE THEREOF IN REGRESSION OF CHRONIC RENAL INSUFFICIENCY, BREAST CAPSULAR CONTRACTURE AND HEPATIC FIBROSIS IN HUMANS |
2012 |
- Armendariz Borunda Khuan
- Maganya Kastro Khose Augustin Rokhelio
- Servantes Guadarrama Khorkhe
|
RU2682177C2 |
| ORVEPITANT FOR CHRONIC COUGH TREATMENT |
2016 |
|
RU2746601C2 |
| AGENT FOR PULMONARY FIBROSIS CONTAINING PYRAZOLE DERIVATIVE |
2021 |
- Moon, Sung Hwan
- Lee, Soo Jin
- Yu, Hyunkyung
- Goh, Yoo-Kyung
|
RU2817989C1 |
| DRUG FOR TREATMENT OF TISSUE FIBROSIS BASED ON COMPONENTS OF SECRETOME OF MESENCHYMAL STROMAL CELLS, METHOD FOR OBTAINING AND APPLYING REMEDY |
2020 |
- Tkachuk Vsevolod Arsenevich
- Akopyan Zhanna Alekseevna
- Efimenko Anastasiya Yurevna
- Arbatskij Mikhail Spartakovich
- Basalova Natalya Andreevna
- Grigoreva Olga Aleksandrovna
- Zajtsev Ivan Leonidovich
- Kalinina Natalya Igorevna
- Novoseletskaya Ekaterina Sergeevna
- Popov Vladimir Sergeevich
- Sagaradze Georgij Dmitrievich
- Tarasova Elena Vladimirovna
|
RU2766707C1 |
| ANTAGONISTS OF ENDOTELINE RECEPTOR INTENDED FOR EARLY STAGE OF IDIOPATIC PULMONARY FIBROSIS |
2007 |
- Klozel' Martina
- Gatfil'D Jon
- Ru Sebast'En
|
RU2435585C2 |
| ANTIBODIES AGAINST EOTAXIN 2, WHICH RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES |
2015 |
|
RU2705255C2 |
| MEDICATION, CONTAINING FGF2 AS ACTIVE INGREDIENT, FOR TREATMENT OR PREVENTION OF ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASES |
2005 |
- Kim Joon-Keun
- Kang Soo Khiung
- Kim Biong Moon
- Son Mivon
|
RU2351356C2 |
| COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF DISEASES, CONDITIONS, OR PROCESSES CHARACTERIZED BY ABERRANT FIBROBLAST PROLIFERATION AND EXTRACELLULAR MATRIX DEPOSITION |
2012 |
- Lender Sintiya
- Brofi Kolin
|
RU2620066C2 |
